Genetic and epigenetic analysis of putative breast cancer stem cell models

BMC Cancer

Volumn 13, Issue , 2013, Pages

  Balic, Marija ^a   Schwarzenbacher, Daniela ^a   Stanzer, Stefanie ^a   Heitzer, Ellen ^a   Auer, Martina ^a   Geigl, Jochen B ^a   Cote, Richard J ^b   Datar, Ram H ^b   Dandachi, Nadia ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE; CD24 ANTIGEN; GENOMIC DNA; HEPATOCYTE NUCLEAR FACTOR 3BETA; HERMES ANTIGEN; HISTONE DEACETYLASE 1; MESSENGER RNA; RGS2 PROTEIN; SMAD2 PROTEIN; TUMOR MARKER; TRANSCRIPTOME;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER STEM CELL; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; CTBP1 GENE; DNA METHYLATION; DSC2 GENE; EPIGENETICS; FLOW CYTOMETRY; FOXA2 GENE; GENE; GENE EXPRESSION REGULATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; HDAC1 GENE; HOXB4 GENE; HOXD3 GENE; HUMAN; HUMAN CELL; LEF1 GENE; PHENOTYPE; PROTEIN EXPRESSION; PYROSEQUENCING; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RGS2 GENE; WIF1 GENE; BREAST TUMOR; FEMALE; GENETIC EPIGENESIS; GENETICS; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ANTIGENS, CD24; BREAST NEOPLASMS; CELL LINE, TUMOR; COMPARATIVE GENOMIC HYBRIDIZATION; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASTIC STEM CELLS; REAL-TIME POLYMERASE CHAIN REACTION; TRANSCRIPTOME;

EID: 84880352757     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-358     Document Type: Article

References (41)

1. Ly D, Forman D, Ferlay J, Brinton LA, Cook MB. An international comparison of male and female breast cancer incidence rates. Int J Cancer 2013, 132(8):1918-1926. 10.1002/ijc.27841, 22987302.
2. Lorico A, Rappa G. Phenotypic heterogeneity of breast cancer stem cells. J Oncol 2011, 2011:135039. 3026971, 21317983.
3. Malinowsky K, Raychaudhuri M, Buchner T, Thulke S, Wolff C, Hofler H, Becker KF, Avril S. Common protein biomarkers assessed by reverse phase protein arrays show considerable intratumoral heterogeneity in breast cancer tissues. PLoS One 2012, 7(7):e40285. 10.1371/journal.pone.0040285, 3390380, 22792263.
4. Raychaudhuri M, Schuster T, Buchner T, Malinowsky K, Bronger H, Schwarz-Boeger U, Hofler H, Avril S. Intratumoral heterogeneity of microRNA expression in breast cancer. J Mol Diagn 2012, 14(4):376-384. 10.1016/j.jmoldx.2012.01.016, 22704963.
5. Cuzick J, Dowsett M, Pineda S, Wale C, Salter J, Quinn E, Zabaglo L, Mallon E, Green AR, Ellis IO, et al. Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the Genomic Health recurrence score in early breast cancer. J Clin Oncol 2011, 29(32):4273-4278. 10.1200/JCO.2010.31.2835, 21990413.
6. Malik F, Korkaya H, Clouthier SG, Wicha MS. Lin28 and HER2: two stem cell regulators conspire to drive aggressive breast cancer. Cell Cycle 2012, 11(15):2780-2781. 10.4161/cc.21395, 3419057, 22833047.
7. Kakarala M, Wicha MS. Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy. J Clin Oncol 2008, 26(17):2813-2820. 10.1200/JCO.2008.16.3931, 2789399, 18539959.
8. Azizi E, Wicha MS. Cancer Stem Cells--The Evidence Accumulates. Clin Chem 2013, 59(1):205-207. 10.1373/clinchem.2012.195990, 23143328.
9. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003, 100(7):3983-3988. 10.1073/pnas.0530291100, 153034, 12629218.
10. Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG, Liu S, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007, 1(5):555-567. 10.1016/j.stem.2007.08.014, 2423808, 18371393.
11. Dontu G, Abdallah WM, Foley JM, Jackson KW, Clarke MF, Kawamura MJ, Wicha MS. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 2003, 17(10):1253-1270. 10.1101/gad.1061803, 196056, 12756227.
12. Oak PS, Kopp F, Thakur C, Ellwart JW, Rapp UR, Ullrich A, Wagner E, Knyazev P, Roidl A. Combinatorial treatment of mammospheres with trastuzumab and salinomycin efficiently targets HER2-positive cancer cells and cancer stem cells. Int J Cancer 2012, 131(12):2808-2819. 10.1002/ijc.27595, 22511343.
13. Venugopal C, Li N, Wang X, Manoranjan B, Hawkins C, Gunnarsson T, Hollenberg R, Klurfan P, Murty N, Kwiecien J, et al. Bmi1 marks intermediate precursors during differentiation of human brain tumor initiating cells. Stem Cell Res 2013, 8(2):141-153.
14. Hardt O, Wild S, Oerlecke I, Hofmann K, Luo S, Wiencek Y, Kantelhardt E, Vess C, Smith GP, Schroth GP, et al. Highly sensitive profiling of CD44+/CD24- breast cancer stem cells by combining global mRNA amplification and next generation sequencing: evidence for a hyperactive PI3K pathway. Cancer Lett 2012, 325(2):165-174. 10.1016/j.canlet.2012.06.010, 22771536.
15. Balic M, Rapp N, Stanzer S, Lin H, Strutz J, Szkandera J, Daidone MG, Samonigg H, Cote RJ, Dandachi N. Novel immunofluorescence protocol for multimarker assessment of putative disseminating breast cancer stem cells. Appl Immunohistochem Mol Morphol 2011, 19(1):33-40. 10.1097/PAI.0b013e3181ebf4e8, 20861793.
16. van Beers EH, Joosse SA, Ligtenberg MJ, Fles R, Hogervorst FB, Verhoef S, Nederlof PM. A multiplex PCR predictor for aCGH success of FFPE samples. Br J Cancer 2006, 94(2):333-337. 10.1038/sj.bjc.6602889, 2361127, 16333309.
17. Geigl JB, Obenauf AC, Waldispuehl-Geigl J, Hoffmann EM, Auer M, Hormann M, Fischer M, Trajanoski Z, Schenk MA, Baumbusch LO, et al. Identification of small gains and losses in single cells after whole genome amplification on tiling oligo arrays. Nucleic Acids Res 2009, 37(15):e105. 10.1093/nar/gkp526, 2731907, 19541849.
18. Stanzer S, Balic M, Strutz J, Heitzer E, Obermair F, Hauser-Kronberger C, Samonigg H, Dandachi N. Rapid and reliable detection of LINE-1 hypomethylation using high-resolution melting analysis. Clin Biochem 2010, 43(18):1443-1448. 10.1016/j.clinbiochem.2010.09.013, 20883681.
19. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008, 3(6):1101-1108. 10.1038/nprot.2008.73, 18546601.
20. Pattyn F, Robbrecht P, De Paepe A, Speleman F, Vandesompele J. RTPrimerDB: the real-time PCR primer and probe database, major update 2006. Nucleic Acids Res 2006, 34(Database issue):D684-D688. 1347517, 16381959.
21. Pattyn F, Speleman F, De Paepe A, Vandesompele J. RTPrimerDB: the real-time PCR primer and probe database. Nucleic Acids Res 2003, 31(1):122-123. 10.1093/nar/gkg011, 165458, 12519963.
22. Fillmore CM, Kuperwasser C. Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy. Breast Cancer Res 2008, 10(2):R25. 10.1186/bcr1982, 2397524, 18366788.
23. Hampton OA, Den Hollander P, Miller CA, Delgado DA, Li J, Coarfa C, Harris RA, Richards S, Scherer SE, Muzny DM, et al. A sequence-level map of chromosomal breakpoints in the MCF-7 breast cancer cell line yields insights into the evolution of a cancer genome. Genome Res 2009, 19(2):167-177. 2652200, 19056696.
24. Shadeo A, Lam WL. Comprehensive copy number profiles of breast cancer cell model genomes. Breast Cancer Res 2006, 8(1):R9. 10.1186/bcr1370, 1413994, 16417655.
25. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, Dirks PB. Identification of human brain tumour initiating cells. Nature 2004, 432(7015):396-401. 10.1038/nature03128, 15549107.
26. Bertolini G, Roz L, Perego P, Tortoreto M, Fontanella E, Gatti L, Pratesi G, Fabbri A, Andriani F, Tinelli S, et al. Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment. Proc Natl Acad Sci USA 2009, 106(38):16281-16286. 10.1073/pnas.0905653106, 2741477, 19805294.
27. Cipak A, Mrakovcic L, Ciz M, Lojek A, Mihaylova B, Goshev I, Jaganjac M, Cindric M, Sitic S, Margaritoni M, et al. Growth suppression of human breast carcinoma stem cells by lipid peroxidation product 4-hydroxy-2-nonenal and hydroxyl radical-modified collagen. Acta Biochim Pol 2010, 57(2):165-171.
28. Huang M, Li Y, Zhang H, Nan F. Breast cancer stromal fibroblasts promote the generation of CD44 + CD24- cells through SDF-1/CXCR4 interaction. J Exp Clin Cancer Res 2010, 29:80. 10.1186/1756-9966-29-80, 2911413, 20569497.
29. Duru N, Fan M, Candas D, Menaa C, Liu HC, Nantajit D, Wen Y, Xiao K, Eldridge A, Chromy BA, et al. HER2-associated radiation resistance of breast cancer stem cells isolated from HER2-negative breast cancer cells. Clin Cancer Res 2012, 18(24):6634-6647. 10.1158/1078-0432.CCR-12-1436, 23091114.
30. Vincent A, Van Seuningen I. On the epigenetic origin of cancer stem cells. Biochim Biophys Acta 2012, 1826(1):83-88.
31. Tang Y, Luo Y, Jiang Z, Ma Y, Lin CJ, Kim C, Carter MG, Amano T, Park J, Kish S, et al. Jak/Stat3 Signaling Promotes Somatic Cell Reprogramming by Epigenetic Regulation. Stem Cells 2012, 30(12):2645-2656. 10.1002/stem.1225, 22968989.
32. Munoz P, Iliou MS, Esteller M. Epigenetic alterations involved in cancer stem cell reprogramming. Mol Oncol 2012, 6(6):620-636. 10.1016/j.molonc.2012.10.006, 23141800.
33. Balic M, Williams A, Lin H, Datar R, Cote RJ. Circulating Tumor Cells: From Bench to Bedside. Annu Rev Med 2012, 64:31-44.
34. Balic M, Lin H, Young L, Hawes D, Giuliano A, McNamara G, Datar RH, Cote RJ. Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype. Clin Cancer Res 2006, 12(19):5615-5621. 10.1158/1078-0432.CCR-06-0169, 17020963.
35. Kagara N, Huynh KT, Kuo C, Okano H, Sim MS, Elashoff D, Chong K, Giuliano AE, Hoon DS. Epigenetic regulation of cancer stem cell genes in triple-negative breast cancer. Am J Pathol 2012, 181(1):257-267. 10.1016/j.ajpath.2012.03.019, 22626806.
36. Park SY, Kwon HJ, Choi Y, Lee HE, Kim SW, Kim JH, Kim IA, Jung N, Cho NY, Kang GH. Distinct patterns of promoter CpG island methylation of breast cancer subtypes are associated with stem cell phenotypes. Mod Pathol 2012, 25(2):185-196.
37. Hernandez-Vargas H, Ouzounova M, Le Calvez-Kelm F, Lambert MP, McKay-Chopin S, Tavtigian SV, Puisieux A, Matar C, Herceg Z. Methylome analysis reveals Jak-STAT pathway deregulation in putative breast cancer stem cells. Epigenetics 2011, 6(4):428-439. 10.4161/epi.6.4.14515, 21266853.
38. Kaur P, Mani S, Cros MP, Scoazec JY, Chemin I, Hainaut P, Herceg Z. Epigenetic silencing of sFRP1 activates the canonical Wnt pathway and contributes to increased cell growth and proliferation in hepatocellular carcinoma. Tumour Biol 2012, 33(2):325-336. 10.1007/s13277-012-0331-5, 22351518.
39. Liu S, Clouthier SG, Wicha MS. Role of microRNAs in the regulation of breast cancer stem cells. J Mammary Gland Biol Neoplasia 2012, 17(1):15-21. 10.1007/s10911-012-9242-8, 22331423.
40. Liu S, Patel SH, Ginestier C, Ibarra I, Martin-Trevino R, Bai S, McDermott SP, Shang L, Ke J, Ou SJ, et al. MicroRNA93 regulates proliferation and differentiation of normal and malignant breast stem cells. PLoS Genet 2012, 8(6):e1002751. 10.1371/journal.pgen.1002751, 3369932, 22685420.
41. Barlow DP. Genomic imprinting: a mammalian epigenetic discovery model. Annu Rev Genet 2011, 45:379-403. 10.1146/annurev-genet-110410-132459, 21942369.